Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House agrees to permanent physician fee fix

This article was originally published in The Gray Sheet

Executive Summary

House votes 243-183 to approve the Medicare Physician Payment Reform Act (H.R. 3961) on Nov. 19. The bill would halt a planned 21% reduction in fees for physician services, and permanently reform the Medicare sustainable growth rate (SGR) method for calculating physician payments, which would annually reduce overall doctor reimbursement if Congress did not step in each year with temporary reversals. Doctors' payment rates under Medicare would increase by 1.2% in 2010, and restructuring of the SGR would begin in 2011, resulting in "significantly higher payment rates for physicians than those that would result under current law," according to the Congressional Budget Office. The Senate rejected a similar bill last month

You may also be interested in...



Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company

The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.

Synthekine Joins Quest To Tame IL-2 In Cancer Therapies

First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.

Swisse Supplements Take Bigger Slice Of Chinese Market

Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028195

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel